Martine Rothblatt's Securities Transactions in United Therapeutics Corp

Martine Rothblatt, the Founder, Chairperson, and CEO of United Therapeutics Corp, has filed a notice of securities transactions. The filing details the sale of 4,000 common shares on October 17, 2025, with an aggregate market value of $1,722,687.20. Additionally, the filing reports multiple sales of common shares over the past three months, totaling 104,000 shares with gross proceeds exceeding $17 million. The securities were acquired through an Executive Deferred Compensation plan adopted on May 2, 2025. The transactions were executed through TD Securities (USA) LLC. This filing provides transparency into the significant securities transactions by a key executive of the company.